YOUR SEARCH FOR Text 220 RESULTS
41 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… Press Release View all news Incyte Reports 2024 Third Quarter Financial … update these forward-looking statements. INCYTE CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF …
42 of Total
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… Press Release View all news Incyte Reports 2025 Second Quarter Financial … update these forward-looking statements. INCYTE CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF …
43 of Total
Supplement to Consumer Health Data Privacy Policy for Nevada Consumers | Incyte.com
… time and across different websites or online services you may visit. Effective Date: March … Data Privacy Policy for Nevada Consumers | Incyte.com …
44 of Total
Prospective Suppliers | Incyte.com
… Prospective Suppliers Incyte is committed to continually identifying … sources both direct and indirect goods and services in direct and indirect categories. …
45 of Total
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Incyte
… Press Release View all news Incyte Reports Inducement Grant Under Nasdaq … subject to Mr. Gardner’s continued service with the Company on each such date. The …
46 of Total
Incyte Gets Involved | Incyte Stories
… May 2, 2024 Incyte Involved: Our Commitment to Community At … centers on matching gifts and community service, enabling employees to donate time and …
47 of Total
Supplier Diversity - Supporting Diverse Communities | Incyte.com
… Supplier Diversity Incyte takes pride in further supporting diverse … we rely on outside support for new goods and services. We seek to develop long-term …
48 of Total
Incyte Involved: Unwavering Community Commitment | Incyte Stories
… May 22, 2025 Incyte Involved: Unwavering Community Commitment … the team through matching gifts and community service days. In 2024, employees generously …
49 of Total
Incyte Leadership | Incyte.com
… and Chief Executive Officer Bill Meury joined Incyte in 2025 as President, Chief Executive … Incyte, he worked at Novartis Pharmaceuticals Corporation, most recently as Senior Vice …
50 of Total
Portfolio: Hematology, Oncology, Dermatology, Other, Partnered Programs | Incyte.com
… ® (pemigatinib) FGFR1/2/3 Cholangiocarcinoma 10 status for mobile retifanlimab 9 PD-1 … including full safety information, on Incyte’s marketed medicines, or on medicines …